on PolyPeptide Group
PolyPeptide Announces Extraordinary General Meeting Amid Samsung Offer
PolyPeptide Group AG has announced an extraordinary general meeting (EGM) of shareholders scheduled for 26 October 2026. The meeting will be held at Dialoghotel Eckstein in Baar, starting at 18:00 CET. This gathering is linked to the public tender offer by Samsung Peptide AG, a subsidiary of Samsung Biologics Co., Ltd., aimed at acquiring all publicly held registered shares of PolyPeptide.
The company, known for its specialized work in peptide-based pharmaceutical ingredients, has provided detailed agenda items and board proposals on its website. PolyPeptide's invitation to the EGM marks a significant step in its ongoing corporate developments involving Samsung.
For more information, shareholders and interested parties are encouraged to consult the company's official communication channels.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all PolyPeptide Group news